default author photo

Cristina Bergamaschi

National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section

Frederick, MD 21702

United States

  • National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section

SCHOLARLY PAPERS

2

DOWNLOADS

101

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies

Number of pages: 47 Posted: 09 Feb 2022
Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, Matthew Angel, Ifigeneia Tzannou, Margarita Vlachou, Ismini Darmani, Amirah Ullah, Jenifer Bear, Santhi Devasundaram, Robert Burns, Ioannis Baltadakis, Stavros Gigantes, Meletios A. Dimopoulos, George N. Pavlakis, Evangelos Terpos and Barbara K. Felber
National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, Evangelismos General Hospital of Athens - Hematology-Lymphomas Department - BMT Unit, National Cancer Institute at Frederick - Human Retrovirus Section, Government of the United States of America - Vaccine Branch, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, affiliation not provided to SSRN, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, affiliation not provided to SSRN, affiliation not provided to SSRN, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National Cancer Institute at Frederick - Human Retrovirus Section, National and Kapodistrian University of Athens - Department of Clinical Therapeutics and Government of the United States of America - Human Retrovirus Pathogenesis Section
Downloads 65 (924,743)

Abstract:

Loading...

humoral response, cytokine, SARS-CoV-2 BNT162b2 mRNA vaccine, IFN-gamma, CXCL10, IL-15

2.

Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated With Effective Immune Response in BNT162b2 mRNA Vaccine Recipients

Number of pages: 47 Posted: 23 Apr 2021
Cristina Bergamaschi, Evangelos Terpos, Matthew Angel, Jenifer Bear, Margherita Rosati, Dimitris Stellas, Sevasti Karaliota, Filia Apostolakou, Tina Bagratuni, Dimitris Patseas, Sentiljana Gumeni, Ioannis P. Trougakos, Meletios A. Dimopoulos, Barbara K. Felber and George N. Pavlakis
National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National Cancer Institute - Vaccine Branch, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Section, "Aghia Sophia" Children's Hospital - Department of Clinical Biochemistry, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National and Kapodistrian University of Athens - Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens - Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section and National Cancer Institute at Frederick - Human Retrovirus Section
Downloads 36 (1,249,711)
Citation 1

Abstract:

Loading...

SARS-CoV-2, mRNA, vaccine, innate immunity, IL-15, IFN-γ, IP10/CXCL10, TNF-, IL-6, Spike-RBD antibody